Nautilus Biotechnology Stock Forecast

Sell candidate since Jun 05, 2026 Loss -63.81%

The Nautilus Biotechnology, Inc. stock price fell by -3.90% on the last day (Monday, 10th Aug 2026) from $0.90 to $0.87. During the last trading day the stock fluctuated 7.42% from a day low at $0.86 to a day high of $0.92. The price has fallen in 8 of the last 10 days and is down by -47.89% for this period. Volume fell on the last day along with the stock, which is actually a good sign as volume should follow the stock. On the last day, the trading volume fell by -121 thousand shares and in total, 796 thousand shares were bought and sold for approximately $688.26 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -57.72% during the next 3 months and, with a 90% probability hold a price between $0.283 and $0.569 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

NAUT Signals & Forecast

There are few to no technical positive signals at the moment. The Nautilus Biotechnology, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.94 and $1.60. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Monday, June 01, 2026, and so far it has fallen -68.77%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD). Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.

Support, Risk & Stop-loss for Nautilus Biotechnology, Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock may move very much during the day (volatility) and with periodic low trading volume this stock is considered to be "very high risk". During the last day, the stock moved $0.0638 between high and low, or 7.42%. For the last week the stock has had daily average volatility of 9.66%.

Nautilus Biotechnology, Inc. is oversold on RSI14 (11). Some stocks may fall long and hard while being oversold on RSI, but stocks that are heavily oversold on RSI often pose good re-bounce chance and played well it can be a buy candidate.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (NAUT) For The Upcoming Trading Day Of Tuesday 11th

For the upcoming trading day on Tuesday, 11th we expect Nautilus Biotechnology, Inc. to open at $0.88, and during the day (based on 14 day Average True Range), to move between $0.80 and $0.93, which gives a possible trading interval of +/-$0.125 (+/-15.61%) up or down from last closing price. If Nautilus Biotechnology, Inc. takes out the full calculated possible swing range there will be an estimated 15.61% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $0.99, some $0.120 (13.91%) from the current price of $0.87, our system finds the risk reward not very attractive.

Is Nautilus Biotechnology, Inc. stock A Buy?

Nautilus Biotechnology, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Strong Sell candidate.

Current score: -5.914 Strong Sell Candidate Downgraded

Predicted Fair Opening Price

Predicted fair opening price on August 11, 2026 - $0.88 ( 2.07%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker*
*Your capital is at risk